The company's new coronavirus-focused pharmaceutical business could fail to receive the funding it needs.
News & Analysis: Eastman Kodak
There was a big division across the broader market.
Kodak's seminal loan agreement may now be in serious jeopardy. Here's why.
President Trump's executive order could provide a boost for the company's fledgling pharmaceutical business.
Strong trading before the official announcement of a $765 million loan spurred the Securities and Exchange Commission to investigate.
A surprising pivot made the struggling photography company one of the hottest stocks on the market.
The film and digital imaging specialist has turned a new leaf, but can it succeed?
Reports of an SEC investigation have investors on edge.
Kodak’s stock went up substantially, shocking everyone. Does this mean the company is back in business?
Chasing these "hot stocks" would not be a wise idea.